Key result
This editorial discusses a methodological approach to a discrete-choice experiment aimed at identifying provider preferences to guide the design of a future HFrEF polypill randomized clinical trial.
This editorial highlights the value of using a discrete-choice experiment to elicit provider preferences when designing a polypill for heart failure with reduced ejection fraction.
In this issue of Journal of Cardiac Failure-Intersections, DeJong and colleagues provide a detailed report of the five-step approach they used to select attributes for inclusion in a discrete-choice experiment (DCE) and the development and piloting of a survey embedding the DCE to inform the design of a polypill for HFrEF for use in a future randomized clinical trial.1 Their plan to elicit providers’ preferences to guide design of a therapy optimized for implementation in clinical care is a forward-thinking effort to pre-emptively address prescribing-related barriers and concerns of patients.
No takes yet. Share an insight, caveat, or question.
Reed et al. (2025) conducted an editorial in Heart Failure With Reduced Ejection Fraction (HFrEF). Polypill for HFrEF was evaluated. This editorial discusses a methodological approach to a discrete-choice experiment aimed at identifying provider preferences to guide the design of a future HFrEF polypill randomized clinical trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: